MIRA INFORM REPORT

 

 

Report No. :

321345

Report Date :

06.05.2015

 

IDENTIFICATION DETAILS

 

Name :

NOVARTIS HEALTHCARE PRIVATE LIMITED (w.e.f. 15.02.2005)

 

 

Formerly Known As :

NOVARTIS CONSUMER HEALTH INDIA PRIVATE LIMITED

 

NOVARTIS NUTRITION INDIA LIMITED

 

NOVARTIS NUTRITION INDIA PRIVATE LIMITED

 

 

Registered Office :

Sandoz House, 8th Floor, Dr. Annie Besant Road, Worli, Mumbai – 400018, Maharashtra

Tel. No.:

91-22-24958400

 

 

Country :

India

 

 

Financials (as on) :

31.03.2014

 

 

Date of Incorporation :

13.10.1997

 

 

Com. Reg. No.:

11-111257

 

 

Capital Investment / Paid-up Capital :

Rs.60.000 Million

 

 

CIN No.:

[Company Identification No.]

U15202MH1997PTC111257

 

 

IEC No.:

Not Available

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

PAN No.:

[Permanent Account No.]

AAACN5094N

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Trading of pharmaceuticals, consumer health products, contact lenses and lense care products and providing services.

 

 

No. of Employees :

Information declined by the management

 

 

RATING & COMMENTS

 

MIRA’s Rating :

A (62)

 

RATING

STATUS

PROPOSED CREDIT LINE

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

Fairly Large

 

Maximum Credit Limit :

USD 6400000

 

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject is a subsidiary of “NOVARTIS PHARMA AG” Switzerland. It is a well-established company having fine track record.

 

For the financial year ended, the company has reported sales turnover of Rs.14292.500 Million with topline growth of 25.80% and it has maintained profitability margins at 4.15%.

 

Rating also takes into consideration company’s healthy operational risk profile marked by adequate liquidity position and decent financial base of the company.

 

Further company receives strong financial and managerial support from its parent company.

 

Trade relations are reported as decent. Payments are reported to be regular and as per commitment.

 

In view of healthy operational track record backed by strong parent company support, the company can be considered good for normal business dealings at usual trade terms and conditions.

 

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – December 31, 2014

 

Country Name

Previous Rating

(30.09.2014)

Current Rating

(31.12.2014)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

EXTERNAL AGENCY RATING

 

Not Available

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2014.

 

 

INFORMATION DENIED BY

 

Name :

Ms. Veena

Designation :

Accounts Executive

Contact No.:

91-22-24958400

Date :

06.05.2015

 

LOCATIONS

 

Registered Office :

Sandoz House, 8th Floor, Dr. Annie Besant Road, Worli, Mumbai – 400018, Maharashtra, India

Tel. No.:

91-22-24958400 / 24958888

Fax No.:

91-22-24950221

E-Mail :

milind.patil@novartis.com

Website :

www.novartis.com

 

 

DIRECTORS

 

AS ON 30.09.2014

 

Name :

Mr. Jawed Zia

Designation :

Director

Address :

Flat E, 76 Diamond District, Airport Road, Kodihalli, Bangalore - 560008, Karnataka, India

Date of Birth/Age :

03.10.1963

Date of Appointment :

28.08.2014

DIN No.:

00191276

 

 

Name :

Mr. Luis Prat Mora

Designation :

Director

Address :

Schweizergasse 33, Basel, 4054, Switzerland

Date of Birth/Age :

12.09.1952

Date of Appointment :

23.06.2007

DIN No.:

01561571

 

 

Name :

Mr. Milind Anil Patil

Designation :

Alternate Director

Address :

Flat No.103, Snehal Apartments, Road No.5, Jaiprakash Nagar, Goregaon (East), Mumbai - 400063, Maharashtra, India

Date of Birth/Age :

01.11.1963

Date of Appointment :

14.02.2009

DIN No.:

02546815

 

 

Name :

Mr. Naveen Gullapalli

Designation :

Whole-time Director

Address :

121, Indu Fortune Fields, Kphb, 7th Phase, Kukatpally, Hyderabad - 500072, Telangana, India

Date of Birth/Age :

21.10.1974

Date of Appointment :

13.06.2014

DIN No.:

06889417

 

 

 

 

KEY EXECUTIVES

 

Name :

Ms. Veena

Designation :

Accounts Executive

 

 

MAJOR SHAREHOLDERS

 

AS ON 30.09.2014

 

Names of Shareholders

 

No. of Shares

% of Holding

Novartis Consumer Health S.A., Switzerland

2940000

49.00

Novartis Pharma AG, Switzerland

3060000

51.00

 

 

 

Total

6000000

100.00

 

 

 

Equity Share Break up (Percentage of Total Equity)

 

AS ON 30.09.2014

 

Category

 

Percentage

Foreign holdings [Foreign institutional investor(s), Foreign companie(s) Foreign financial institution(s), Non-resident Indian(s) or Overseas Corporate bodies or Others]

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Trading of pharmaceuticals, consumer health products, contact lenses and lense care products and providing services.

 

 

Products :

  • Pharmaceuticals
  • Consumer Health Products
  • Contact Lenses
  • Lense Care Products

 

 

Brand Names :

Not Divulged

 

 

Agencies Held :

Not Divulged

 

 

Exports :

Not Divulged

 

 

Imports :

Not Divulged

 

 

Terms :

 

Selling :

Not Divulged

 

 

Purchasing :

Not Divulged

 

 

PRODUCTION STATUS – NOT AVAILABLE

 

 

GENERAL INFORMATION

 

Suppliers :

Company Name :

Not Divulged

Name of the Person :

Not Divulged

Contact No.:

Not Divulged

Since How Long Known :

Not Divulged

Maximum Limit Dealt :

Not Divulged

Experience :

Not Divulged

Remark :

Not Divulged

 

 

Customers :

Company Name :

Not Divulged

Name of the Person :

Not Divulged

Contact No.:

Not Divulged

Since How Long Known :

Not Divulged

Maximum Limit Dealt :

Not Divulged

Experience :

Not Divulged

Remark :

Not Divulged

 

 

No. of Employees :

Information declined by the management

 

 

Bankers :

Banker Name :

Union Bank of India

Branch :

Industrial Finance Branch, Union Bank Bhawan, 239, Vikas Bhawan Marg, Nariman Point, Mumbai – 400021, Maharashtra, India

Person Name (With Designation) :

Not Divulged

Contact Number :

Not Divulged

Name of Account Holder :

Not Divulged

Account Number :

Not Divulged

Account Since (Date/Year of Account Opening) :

Not Divulged

Average Balance Maintained :

Not Divulged

Credit Facilities Enjoyed (CC/OD/Term Loan) :

Not Divulged

Account Operation :

Not Divulged

Remark :

Not Divulged

 

 

 

Auditors :

 

Name :

Lovelock and Lewes

Chartered Accountants

Address :

252,Veer Savarkar Marg, Shivaji Park, Dadar, Mumbai – 400028, Maharashtra, India

PAN No.:

AABFL5878L

 

 

Collaborators :

Not Divulged

 

 

Membership :

Not Divulged

 

 

Ultimate Holding Company :

·         Novartis AG, Switzerland

 

 

Holding Company :

·         Novartis Pharma AG, Switzerland

 

 

Fellow Subsidiaries :

·         Alcon Laboratories (India) Private Limited, India

·         Alcon Pharmaceuticals Ltd., Switzerland

·         Befico Limited, Bermuda

·         Chiron Behring Vaccines Private Limited, India

·         CIBA Vision Asian Manufacturing and Logistics Pte Limited, Singapore

·         CIBA Vision Corporation, USA

·         Novartis Asia Pacific Pharmaceuticals Pte Limited, Singapore

·         Novartis Consumer Health S.A., Switzerland

·         Novartis India Limited, India

·         Novartis International AG, Switzerland

·         Novartis Pharma K.K., Japan

·         Novartis Pharma B.V., Netherlands

·         Novartis Pharmaceuticals Canada Inc, Canada

·         Novartis Pharmaceuticals Australia Pty. Limited, Australia

·         Novartis Pharmaceuticals Corporation, USA

·         Novartis Pharmaceuticals UK Limited, UK

·         Novartis Poland Sp.Zo.o, Poland

·         Novartis South Africa (Pty) Limited, South Africa

·         Novartis Vaccines and Diagnostics AG, Switzerland

·         Novartis Vaccines and Diagnostics GMBH, Germany

·         Novartis Vaccines and Diagnostics (HK) Limited, Hong Kong

·         Novartis Vaccines and Diagnostics Inc., USA

·         Novartis Vaccines and Diagnostics S.r.l., Italy

·         PT Novartis Indonesia, Indonesia

·         Sandoz Private Limited, India

·         Shanghai Novartis Trading Limited, China

 

 

CAPITAL STRUCTURE

 

AS ON 30.09.2014

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

6000000

Equity Shares

Rs.10/- each

Rs.60.000 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

6000000

Equity Shares

Rs.10/- each

Rs.60.000 Million

 

 

 

 

 


FINANCIAL DATA

[all figures are in Rupees Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2014

31.03.2013

31.03.2012

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

60.000

60.000

60.000

(b) Reserves & Surplus

2188.000

1542.500

1046.600

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

2248.000

1602.500

1106.600

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

0.000

0.000

0.000

(b) Deferred tax liabilities (Net)

0.000

0.000

0.000

(c) Other long term liabilities

8.300

10.600

0.000

(d) long-term provisions

376.800

296.100

163.400

Total Non-current Liabilities (3)

385.100

306.700

163.400

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

838.900

1550.800

1318.500

(b) Trade payables

1578.100

1186.100

1049.500

(c) Other current liabilities

963.900

900.000

571.400

(d) Short-term provisions

108.000

61.400

40.300

Total Current Liabilities (4)

3488.900

3698.300

2979.700

 

 

 

 

TOTAL

6122.000

5607.500

4249.700

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

962.300

828.000

698.200

(ii) Intangible Assets

0.000

0.000

0.000

(iii) Capital work-in-progress

170.500

413.700

148.500

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.000

0.000

0.000

(c) Deferred tax assets (net)

315.600

200.500

124.800

(d)  Long-term Loan and Advances

585.100

376.600

334.500

(e) Other Non-current assets

1.000

0.700

0.700

Total Non-Current Assets

2034.500

1819.500

1306.700

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

947.400

665.400

521.100

(c) Trade receivables

1165.200

1402.200

1109.400

(d) Cash and cash equivalents

15.600

14.400

11.000

(e) Short-term loans and advances

581.100

357.400

417.400

(f) Other current assets

1378.200

1348.600

884.100

Total Current Assets

4087.500

3788.000

2943.000

 

 

 

 

TOTAL

6122.000

5607.500

4249.700

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2014

31.03.2013

31.03.2012

 

 

 

 

 

 

REVENUE FROM OPERATIONS (NET)

14292.500

11360.200

8086.500

 

 

 

 

 

Less

EXPENSES

NA

NA

NA

 

 

 

 

 

 

PROFIT/(LOSS) BEFORE TAX      

962.600

745.100

526.800

 

 

 

 

 

Less

TAX                                                                 

317.100

249.200

178.600

 

 

 

 

 

 

PROFIT/(LOSS) AFTER TAX

645.500

495.900

348.200

 

 

 

 

 

 

Earnings Per Share (Rs.)

107.58

82.65

58.03

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2014

31.03.2013

31.03.2012

Return on Total Assets

(PBT/Total Assets)

(%)

17.08

14.92

13.25

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.43

0.46

0.48

 

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

0.37

0.97

1.19

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.17

1.02

0.99

 

 

 

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2012

31.03.2013

31.03.2014

 

Rs. In Million

Rs. In Million

Rs. In Million

Share Capital

60.000

60.000

60.000

Reserves & Surplus

1046.600

1542.500

2188.000

Share Application money pending allotment

0.000

0.000

0.000

Net worth

1106.600

1602.500

2248.000

 

 

 

 

long-term borrowings

0.000

0.000

0.000

Short term borrowings

1318.500

1550.800

838.900

Total borrowings

1318.500

1550.800

838.900

Debt/Equity ratio

1.191

0.968

0.373

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2012

31.03.2013

31.03.2014

 

Rs. In Million

Rs. In Million

Rs. In Million

Revenue from Operations (Net)

8086.500

11360.200

14292.500

 

 

40.484

25.812

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2012

31.03.2013

31.03.2014

 

Rs. In Million

Rs. In Million

Rs. In Million

Revenue from Operations (Net)

8086.500

11360.200

14292.500

Profit

348.200

495.900

645.500

 

4.31%

4.37%

4.52%

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

-----------

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

----------

22]

Litigations that the firm / promoter involved in

----------

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

----------

26]

Buyer visit details

----------

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

UNSECURED LOANS:

 

Particulars

31.03.2014

Rs. In Million

31.03.2013

Rs. In Million

Short Term Borrowings

 

 

Loans and advances from others

838.900

1550.800

 

 

 

Total

838.900

1550.800

 

 

INDEX OF CHARGE:

 

Sr. No.

Charge ID

Date of Charge Creation/Modification

Charge amount secured

Charge Holder

Address

Service Request Number (SRN)

1

90147212

21/09/1998

20,000,000.00

Union Bank of India

Industrial Finance Branch; Union Bank Bhawan, 239; Vikas Bhawan Marg; Nariman Point, Mumbai, Maharashtra - 400021, India

-

 

 

FIXED ASSETS:

 

·         Land

·         Building

·         Plant and Machinery

·         Furniture and Fixture

·         Office Equipment

·         Computer

·         Vehicles

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.63.52

UK Pound

1

Rs.95.96

Euro

1

Rs.70.54

 

 

INFORMATION DETAILS

 

Information Gathered by :

DIP

 

 

Analysis Done by :

KAR

 

 

Report Prepared by :

NKT


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

7

PAID-UP CAPITAL

1~10

6

OPERATING SCALE

1~10

7

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

7

--PROFITABILITY

1~10

7

--LIQUIDITY

1~10

7

--LEVERAGE

1~10

7

--RESERVES

1~10

7

--CREDIT LINES

1~10

7

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

 

 

 

TOTAL

 

62

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NB

NEW BUSINESS

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.